Summit Therapeutics Inc. (SMMT) Operating cash flow 2018–2025
Summit Therapeutics Inc. (SMMT) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$322.9MFY2025 · since FY2018: -$21.5M → -$322.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$322.9M | -127.2% |
| FY2024 | -$142.1M | -85.1% |
| FY2023 | -$76.8M | -84.6% |
| FY2022 | -$41.6M | +42.7% |
| FY2021 | -$72.6M | -50.9% |
| FY2020 | -$48.1M | -37.0% |
| FY2019 | -$35.1M | -63.3% |
| FY2018 | -$21.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice